BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1612334)

  • 1. Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats.
    Kleber G; Braillon A; Gaudin C; Champigneulle B; Cailmail S; Lebrec D
    Gastroenterology; 1992 Jul; 103(1):282-8. PubMed ID: 1612334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver.
    Villamediana LM; Sanz E; Fernandez-Gallardo S; Caramelo C; Sanchez Crespo M; Braquet P; Lopez-Novoa JM
    Life Sci; 1986 Jul; 39(3):201-5. PubMed ID: 3755490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats.
    Pons L; Droy-Lefaix MT; Braquet P; Bueno L
    Gastroenterology; 1991 Apr; 100(4):946-53. PubMed ID: 1672116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
    Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
    Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis.
    Yang YP; Ma XM; Wang CP; Han J; Lu YY; Xiang Y; Su SH; Feng YY
    World J Gastroenterol; 2006 Feb; 12(5):709-15. PubMed ID: 16521183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and hemodynamic alterations in cirrhotic rats.
    Champigneulle B; Braillon A; Kleber G; Gaudin C; Cailmail S; Lebrec D
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G543-7. PubMed ID: 2018130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Stroke; 1990 Mar; 21(3):459-62. PubMed ID: 2309270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C; Guc MO; Furman BL; Parratt JR
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with hyperdynamic or hypodynamic circulation and role of platelet-activating factor in hemodynamic alterations in bacterial peritonitis in conscious rats.
    Novo C; Ais G; López-Farré A; Romeo JM; Pérez-Barriocanal F; López-Novoa JM
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):937-42. PubMed ID: 8606531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
    Zhou W; Chao W; Levine BA; Olson MS
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
    Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats.
    Pons L; Droy-Lefaix MT; Braquet P; Buéno L
    Life Sci; 1989; 45(6):533-41. PubMed ID: 2570338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
    Sirén AL; Feuerstein G
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model.
    Ais G; López-Farre A; Gomez-Garre DN; Novo C; Romeo JM; Braquet P; López-Novoa JM
    Gastroenterology; 1992 Jan; 102(1):181-7. PubMed ID: 1727752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.